2026 NPPES data Transplant Hepatology Physician NPI 1700271830 M.D.
Verify on CMS →

JASLEEN SINGH, M.D.

Transplant Hepatology Physician in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
222
Medicare Part D claims · 76 beneficiaries · Transplant Hepatology Physician avg: 536
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.7756/100
▲ 12 pts above national avg 83.1 · [object Object]
Industry payments
$6.3K
19 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JASLEEN SINGH, M.D. reported a CMS MIPS final score of 94.7756/100 — above the 83.1 national average — and filed 222 Medicare Part D claims in 2023.

94.7756/100
MIPS score · +12 vs avg
222
Part D claims, 2023
81%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JASLEEN SINGH, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

95 Top 25% higher than 75% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JASLEEN SINGH, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JASLEEN SINGH, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 04/06/2015

NPI 1700271830

Primary specialty

Transplant Hepatology Physician

Rare

131 US NPIs in this specialty

Medicare Part D claims

222 59% vs specialty avg

2023 prescription claims

Specialty avg: 536

MIPS final score

94.7756/100 11.675600000000003% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Transplant Hepatology Physician compares to other specialties among California providers

California providers

Transplant Hepatology Physician share within California

1. Transplant Hepatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Transplant Hepatology Physician share within California

Medicare quality performance — MIPS

JASLEEN SINGH, M.D.'s 2023 MIPS final score plotted against the Transplant Hepatology Physician national average

High performer (top quartile)
MIPS Final Score
94.7756/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Transplant Hepatology Physician) — 94.7756/100 vs national avg 83.1

0%100%National avg83%94.8%
MIPS final score (Transplant Hepatology Physician) — 94.7756/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JASLEEN SINGH, M.D. appears in the CMS NPPES registry as a Transplant Hepatology Physician provider holding M.D. credentials at 100 UCLA MEDICAL PLAZA SUITE 700, LOS ANGELES, CA, 90095, with a listed phone of (310) 794-7783. NPI 1700271830 was issued on 04/06/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SINGH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 222 prescription claims written by this provider, covering 76 Medicare beneficiaries and totaling roughly $570K in drug spend, split 19% brand-name and 81% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.7756/100 for the 2023 performance year (Quality 61.6519, Cost 87.6002), compared with the national average of 83.1.

Transplant Hepatology Physician is a narrow specialty nationwide, with 131 enrolled providers across 36 states and an average of 536 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

100 UCLA MEDICAL PLAZA SUITE 700
LOS ANGELES, CA 90095

Provider Details

NPI 1700271830
Specialty Transplant Hepatology Physician
Credentials M.D.
Gender Female
NPI Issued 04/06/2015

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

94.7756
Final Score
Avg: 83.1
61.6519
Quality
87.6002
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where JASLEEN SINGH, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
LOS ANGELES, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JASLEEN SINGH, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$6.3K

Largest payer

Madrigal Pharmaceuticals

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to JASLEEN SINGH, M.D.. To verify JASLEEN SINGH, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

JASLEEN SINGH, M.D. — brand share 19.0%
Specialty average (est.)

19% brand-name claims vs 81% generic, on 222 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

222
Total Claims
$570K
Total Drug Cost
76
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
293
Total Day Supply
7,158
Brand vs Generic
19% brand / 81% generic
Brand Drug Cost
$559K
Generic Drug Cost
$11K
Antibiotic Claims
13

Patient Demographics

Average Patient Age
68.4 years
Avg HCC Risk Score
3.10
Gender Split
53% female / 47% male
Age Distribution
<65: 18, 65-74: 41, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JASLEEN SINGH, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Spironolactone
24
Ursodiol
22
Furosemide
18
Epclusa
Sofosbuvir/Velpatasvir
17
Lactulose
17
Pantoprazole Sodium
15
Prednisone
13
Mycophenolate Mofetil
12
Gavilyte-G
"Peg3350/Sod Sulf
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Transplant Hepatology Physician Overview

How JASLEEN SINGH, M.D. fits within the Transplant Hepatology Physician landscape nationally.

131
Transplant Hepatology Physician Providers in US
36
States with Transplant Hepatology Physician
536
Avg Claims per Provider

JASLEEN SINGH, M.D.'s 222 claims are below the specialty average of 536.

Nearby Transplant Hepatology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as SINGH.

Compare Transplant Hepatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JASLEEN SINGH, M.D.'s specialty?
JASLEEN SINGH, M.D. specializes in Transplant Hepatology Physician and practices in LOS ANGELES, California. Credentials: M.D..
How much does JASLEEN SINGH, M.D. prescribe under Medicare Part D?
In 2023, JASLEEN SINGH, M.D. wrote 222 Medicare Part D claims totaling $570K in drug costs for 76 beneficiaries.
What is JASLEEN SINGH, M.D.'s Medicare quality score?
JASLEEN SINGH, M.D. has a CMS MIPS Final Score of 94.7756/100 (Quality: 61.6519, Cost: 87.6002). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JASLEEN SINGH, M.D. located?
JASLEEN SINGH, M.D. is located at 100 UCLA MEDICAL PLAZA SUITE 700, LOS ANGELES, CA, 90095. Phone: (310) 794-7783.
What is JASLEEN SINGH, M.D.'s NPI number?
JASLEEN SINGH, M.D.'s National Provider Identifier (NPI) is 1700271830, issued on 04/06/2015.
Does JASLEEN SINGH, M.D. prescribe more brand-name or generic drugs?
JASLEEN SINGH, M.D.'s prescribing is 19% brand-name and 81% generic drugs by claim count, with $559K in brand drug costs.
How many Transplant Hepatology Physician providers are there in the US?
There are 131 Transplant Hepatology Physician providers across 36 states in the US. The average Transplant Hepatology Physician provider writes 536 Medicare Part D claims per year.
What drugs does JASLEEN SINGH, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JASLEEN SINGH, M.D.'s most frequently prescribed drugs include Spironolactone, Ursodiol, Furosemide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JASLEEN SINGH, M.D. accept Medicare?
JASLEEN SINGH, M.D. appears in CMS Medicare data with 222 Part D claims and 76 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JASLEEN SINGH, M.D.'s credentials?
JASLEEN SINGH, M.D.'s NPI is 1700271830 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology